30 Sep 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Novartis and Malaria No More and have launched a global digital fundraising campaign called ‘Power of One' (www.Po1.org) to eliminate malaria deaths among children in Africa through the latest online and mobile technology. The initiative will see Novartis donate up to three million full courses of pediatric antimalarial Coartem Dispersible and is part of Novartis Malaria Initiative.
Additional sponsors of the initiative include Alere (which will provide malaria rapid diagnostic tests), 21st Century Fox, AHAlife.com, Causes.com, Time Warner, Twitter, Venmo and others. Zambia will be the first country to receive deliveries of treatments and tests as a result of the Power of One campaign.
Power of One, uses social, mobile, and e-commerce technologies, and enables the public to purchase a treatment and track the journey of a treatment. Donors will be able to see the effect of their donation on the ground, share information with their networks and recruit other donors.
Mr Joseph Jimenez, CEO, Novartis, said that, "I am proud of the significant and longstanding commitment Novartis has to the fight against malaria. For all our progress though, there's still more work to do. We need more help to close the treatment gap and Power of One offers everyone a chance to engage and make a difference for children suffering from malaria."
Mr Martin Edlund, CEO, Malaria No More, said that, "It's unacceptable that a child dies every minute for lack of a dollar's worth of treatment. We're urging the world to join the Power of One campaign and to donate and engage their friends in this fight."